alovudine has been researched along with Glioblastoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brahm, CG; de Groot, JC; de Vries, EGE; den Dunnen, WFA; den Hollander, MW; Enting, RH; Heesters, MAAM; Pruim, J; Solouki, AM; Verheul, HMW; Wagemakers, M; Walenkamp, AME | 1 |
| Burgess, TL; Coxon, A; Gambhir, SS; Glaus, C; Gobalakrishnan, S; Lewis, XZ; Radinsky, R; Rex, K; Silva, MD | 1 |
| Benci, JL; Chandrasekaran, S; Davis, JJ; Dorsey, JF; Hollander, A; Kao, G; Xu, X | 1 |
| Boehm-Sturm, P; Hoehn, M; Jacobs, AH; Monfared, P; Neumaier, B; Rapic, S; Viel, T | 1 |
| Demirci, E; Laymon, CM; Lieberman, FS; Mountz, JM; Oborski, MJ | 1 |
| Bao, X; Wang, MW; Zhang, YJ; Zhang, YP | 1 |
| Barré, L; Bernaudin, M; Bouquet, F; Corroyer-Dulmont, A; Divoux, D; Gérault, AN; Ibazizène, M; MacKenzie, ET; Pérès, EA; Petit, E; Savina, A; Toutain, J; Valable, S | 1 |
| Erler, J; Kjaer, A; Lassen, U; Michaelsen, SR; Nedergaard, MK; Perryman, L; Poulsen, HS; Stockhausen, MT | 1 |
| Delattre, JY; Goldman, S; Petrirena, GJ | 1 |
| Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
| Chen, J; Xu, T | 1 |
| Cai, W; Chen, K; Chen, X; Hou, LC; Hsu, AR; Kim, S; Mohamedali, KA; Rosenblum, MG; Tse, V; Veeravagu, A; Vogel, H | 1 |
2 review(s) available for alovudine and Glioblastoma
| Article | Year |
|---|---|
Advances in PET imaging of brain tumors: a referring physician's perspective.
Topics: Brain Neoplasms; Carbon Radioisotopes; Dideoxynucleosides; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Nitroimidazoles; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Dideoxynucleosides; Glioblastoma; Humans; Immunotherapy; Interleukin-13 Receptor alpha2 Subunit; Neoplasm Recurrence, Local; Radiosurgery; Reoperation; Temozolomide | 2013 |
1 trial(s) available for alovudine and Glioblastoma
| Article | Year |
|---|---|
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
Topics: Adult; Aged; Cell Proliferation; Chemoradiotherapy; Diagnosis, Differential; Dideoxynucleosides; Disease Progression; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography | 2018 |
9 other study(ies) available for alovudine and Glioblastoma
| Article | Year |
|---|---|
Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Glioblastoma; Hepatocyte Growth Factor; Humans; Mice; Molecular Targeted Therapy; Positron-Emission Tomography; Time Factors; Xenograft Model Antitumor Assays | 2013 |
18F-fluorothymidine-pet imaging of glioblastoma multiforme: effects of radiation therapy on radiotracer uptake and molecular biomarker patterns.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Female; Glioblastoma; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2013 |
Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI.
Topics: Animals; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Glioblastoma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Positron-Emission Tomography; Rats; Rats, Nude | 2013 |
Assessment of early therapy response with 18F-FLT PET in glioblastoma multiforme.
Topics: Brain Neoplasms; Dideoxynucleosides; Female; Glioblastoma; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2014 |
Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Drug Monitoring; Early Detection of Cancer; Female; Glioblastoma; Indoles; Mice; Mice, Inbred C57BL; Mice, Nude; Multimodal Imaging; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Dideoxynucleosides; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2016 |
Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Transformation, Neoplastic; Dideoxynucleosides; Female; Glioblastoma; HEK293 Cells; Humans; Mice; Microvessels; Positron-Emission Tomography; Survival Analysis; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
Topics: Animals; Blood-Brain Barrier; Copper Radioisotopes; Dideoxynucleosides; Glioblastoma; Magnetic Resonance Imaging; Mice; Plant Proteins; Positron-Emission Tomography; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Ribosome Inactivating Proteins, Type 1; Vascular Endothelial Growth Factor A | 2007 |